Page last updated: 2024-09-04

resiquimod and Graft vs Host Disease

resiquimod has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anagnostopoulos, A; Iordanidis, F; Karponi, G; Malasidis, S; Papadopoulou, A; Paraskevas, V; Scouras, ZG; Yannaki, E; Zogas, N	1

Other Studies

1 other study(ies) available for resiquimod and Graft vs Host Disease

Article	Year
The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease. Cytotherapy, 2018, Volume: 20, Issue:1 Topics: Acute Disease; Animals; Antiviral Agents; Gene Expression Regulation; Gene Ontology; Graft vs Host Disease; Imidazoles; Immune Tolerance; Immunologic Memory; Inflammation Mediators; Ligands; Lymphocyte Activation; Mice; Phenotype; Signal Transduction; T-Lymphocytes, Regulatory; Toll-Like Receptor 7	2018

Article

Year

The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.

Cytotherapy, 2018, Volume: 20, Issue:1

Topics: Acute Disease; Animals; Antiviral Agents; Gene Expression Regulation; Gene Ontology; Graft vs Host Disease; Imidazoles; Immune Tolerance; Immunologic Memory; Inflammation Mediators; Ligands; Lymphocyte Activation; Mice; Phenotype; Signal Transduction; T-Lymphocytes, Regulatory; Toll-Like Receptor 7

2018